Please find enclosed herewith the Un-audited Financial Results of the Company for the quarter ended 31st December, 2025 as approved by the Board.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.3 pts more than Nifty Microcap 250 and 8.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Narmada Gelatines has reported its unaudited financial results for Q3 FY26 (quarter ended December 2025) and the nine-month period, approved by the Board on February 12, 2026. Standalone revenue from operations rose to Rs 5,673 lakhs in Q3 FY26 from Rs 4,802 lakhs in Q3 FY25, while nine-month revenue grew to Rs 15,371 lakhs from Rs 13,915 lakhs. Standalone profit after tax surged to Rs 740 lakhs in Q3 (up from Rs 428 lakhs) and Rs 1,886 lakhs for nine months (up from Rs 1,211 lakhs), translating to EPS of Rs 12.23 for the quarter. Consolidated nine-month PAT including share from associate IGCL came in at Rs 2,177 lakhs. The statutory auditors Lodha & Co LLP issued an unmodified limited review report on both standalone and consolidated results, with no qualifications or concerns raised.
Strong double-digit growth in both revenue and profits signals healthy operational momentum for the gelatin/ossein maker, likely to be viewed positively by shareholders. The clean auditor report and no exceptional items reduce near-term governance concerns.